{"transactions":[{"id":691996,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T01:36:04.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 11,500 (638 post-split) RSUs, vesting on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 11,500 (638 post-split) RSUs, vesting on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":638},"source":{"system":"sec-edgar","filing":"0001193125-26-343076","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000119312526343076/ownership.xml","form_type":"4"}},{"id":691995,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Common Stock","published_at":"2026-08-11T01:36:04.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":638,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":638,"source":{"system":"sec-edgar","filing":"0001193125-26-343076","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000119312526343076/ownership.xml","form_type":"4"}},{"id":1071450,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2025-08-08T20:29:09.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":11500,"derivative":{"underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0000950170-25-105894","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017025105894/ownership.xml","form_type":"4"}},{"id":1084113,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2025-07-21T20:37:27.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":false,"shares":3,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 8,550 (11 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 8,550 (11 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025."}],"balance_after":8,"derivative":{"underlying":"Common Stock","underlying_shares":11},"source":{"system":"sec-edgar","filing":"0000950170-25-097271","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017025097271/ownership.xml","form_type":"4"}},{"id":1084112,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Common Stock","published_at":"2025-07-21T20:37:27.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":true,"shares":3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":4,"source":{"system":"sec-edgar","filing":"0000950170-25-097271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017025097271/ownership.xml","form_type":"4"}},{"id":1229400,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2025-03-04T21:36:04.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0000950170-25-032201","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017025032201/ownership.xml","form_type":"4"}},{"id":1229399,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2025-03-04T21:36:04.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."}],"balance_after":2,"derivative":{"underlying":"Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0000950170-25-032201","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017025032201/ownership.xml","form_type":"4"}},{"id":1229398,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Common Stock","published_at":"2025-03-04T21:36:04.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":25,"source":{"system":"sec-edgar","filing":"0000950170-25-032201","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017025032201/ownership.xml","form_type":"4"}},{"id":1229397,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Common Stock","published_at":"2025-03-04T21:36:04.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":true,"shares":2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":23,"source":{"system":"sec-edgar","filing":"0000950170-25-032201","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017025032201/ownership.xml","form_type":"4"}},{"id":1437007,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2024-08-09T20:35:14.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":false,"shares":213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 18,750 (426 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 18,750 (426 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":213},"source":{"system":"sec-edgar","filing":"0000950170-24-094819","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017024094819/ownership.xml","form_type":"4"}},{"id":1437006,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Common Stock","published_at":"2024-08-09T20:35:14.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":true,"shares":213,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":801,"source":{"system":"sec-edgar","filing":"0000950170-24-094819","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017024094819/ownership.xml","form_type":"4"}},{"id":1451271,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2024-07-19T20:35:59.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":8550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in three approximately equal annual installments beginning on July 17, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in three approximately equal annual installments beginning on July 17, 2025."}],"balance_after":8550,"derivative":{"underlying":"Common Stock","underlying_shares":8550},"source":{"system":"sec-edgar","filing":"0000950170-24-084953","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017024084953/ownership.xml","form_type":"4"}},{"id":1495330,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2024-06-03T20:31:21.000Z","date":"2024-05-31","kind":"exercise","planned":false,"acquired":false,"shares":42,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 5,500 (125 post-reverse split) RSUs, vesting in three approximately equal annual installments beginning on May 31, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 5,500 (125 post-reverse split) RSUs, vesting in three approximately equal annual installments beginning on May 31, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":42},"source":{"system":"sec-edgar","filing":"0000950170-24-068036","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017024068036/ownership.xml","form_type":"4"}},{"id":1495329,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Common Stock","published_at":"2024-06-03T20:31:21.000Z","date":"2024-05-31","kind":"exercise","planned":false,"acquired":true,"shares":42,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":588,"source":{"system":"sec-edgar","filing":"0000950170-24-068036","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017024068036/ownership.xml","form_type":"4"}},{"id":1597383,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2024-03-05T21:07:18.000Z","date":"2024-03-03","kind":"exercise","planned":false,"acquired":false,"shares":3667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."}],"balance_after":3667,"derivative":{"underlying":"Common Stock","underlying_shares":3667},"source":{"system":"sec-edgar","filing":"0000950170-24-025881","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017024025881/ownership.xml","form_type":"4"}},{"id":1597382,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2024-03-05T21:07:18.000Z","date":"2024-03-02","kind":"exercise","planned":false,"acquired":false,"shares":3667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."}],"balance_after":7333,"derivative":{"underlying":"Common Stock","underlying_shares":3667},"source":{"system":"sec-edgar","filing":"0000950170-24-025881","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017024025881/ownership.xml","form_type":"4"}},{"id":1597381,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Common Stock","published_at":"2024-03-05T21:07:18.000Z","date":"2024-03-03","kind":"exercise","planned":false,"acquired":true,"shares":3667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":24042,"source":{"system":"sec-edgar","filing":"0000950170-24-025881","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017024025881/ownership.xml","form_type":"4"}},{"id":1597380,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Common Stock","published_at":"2024-03-05T21:07:18.000Z","date":"2024-03-02","kind":"exercise","planned":false,"acquired":true,"shares":3667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":20375,"source":{"system":"sec-edgar","filing":"0000950170-24-025881","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000095017024025881/ownership.xml","form_type":"4"}},{"id":1810982,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2023-08-10T12:44:12.000Z","date":"2023-08-08","kind":"exercise","planned":false,"acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 18,750 RSUs, vesting in two approximately equal installments beginning on August 8, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 18,750 RSUs, vesting in two approximately equal installments beginning on August 8, 2023."}],"balance_after":9375,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001209191-23-045265","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000120919123045265/doc4.xml","form_type":"4"}},{"id":1810981,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Common Stock","published_at":"2023-08-10T12:44:12.000Z","date":"2023-08-08","kind":"exercise","planned":false,"acquired":true,"shares":9375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":16708,"source":{"system":"sec-edgar","filing":"0001209191-23-045265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000120919123045265/doc4.xml","form_type":"4"}},{"id":1870282,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2023-06-02T20:39:35.000Z","date":"2023-05-31","kind":"exercise","planned":false,"acquired":false,"shares":1834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 1, 2021, the reporting person was granted 5,500 RSUs, vesting in three approximately equal annual installments beginning on May 31, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 1, 2021, the reporting person was granted 5,500 RSUs, vesting in three approximately equal annual installments beginning on May 31, 2022."}],"balance_after":1833,"derivative":{"underlying":"Common Stock","underlying_shares":1834},"source":{"system":"sec-edgar","filing":"0001209191-23-033823","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000120919123033823/doc4.xml","form_type":"4"}},{"id":1870281,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Common Stock","published_at":"2023-06-02T20:39:35.000Z","date":"2023-05-31","kind":"exercise","planned":false,"acquired":true,"shares":1834,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":7333,"source":{"system":"sec-edgar","filing":"0001209191-23-033823","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000120919123033823/doc4.xml","form_type":"4"}},{"id":1966345,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-07T21:42:39.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in three approximately equal annual installments beginning on March 2, 2024."}],"balance_after":11000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-23-016786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000120919123016786/doc4.xml","form_type":"4"}},{"id":1966344,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2023-03-07T21:42:39.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in three approximately equal annual installments beginning on March 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in three approximately equal annual installments beginning on March 2, 2024."}],"balance_after":11000,"derivative":{"underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-23-016786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000120919123016786/doc4.xml","form_type":"4"}},{"id":1966343,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Restricted Stock Unit","published_at":"2023-03-07T21:42:39.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":3666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 7, 2022, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 7, 2022, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."}],"balance_after":7334,"derivative":{"underlying":"Common Stock","underlying_shares":3666},"source":{"system":"sec-edgar","filing":"0001209191-23-016786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000120919123016786/doc4.xml","form_type":"4"}},{"id":1966342,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, BD & Corp Affairs"}}],"security":"Common Stock","published_at":"2023-03-07T21:42:39.000Z","date":"2023-03-03","kind":"exercise","acquired":true,"shares":3666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":5499,"source":{"system":"sec-edgar","filing":"0001209191-23-016786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000120919123016786/doc4.xml","form_type":"4"}},{"id":2189710,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC and Corporate Affairs"}}],"security":"Restricted Stock Unit","published_at":"2022-08-10T20:14:41.000Z","date":"2022-08-09","kind":"grant","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in two approximately equal annual installments beginning on August 8, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in two approximately equal annual installments beginning on August 8, 2023."}],"balance_after":18750,"derivative":{"underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-22-045189","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000120919122045189/doc4.xml","form_type":"4"}},{"id":2240442,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC and Corporate Affairs"}}],"security":"Restricted Stock Unit","published_at":"2022-06-07T21:24:24.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"As previously disclosed in a Form 4 filed on March 4, 2022, the reporting person was granted 11,000 options on such date.  At the time of the grant, there were insufficient shares available for issuance under the Aptevo Therapeutics Inc. 2018 Stock Incentive Plan to make the full grant of equity award to the reporting person that was approved for issuance by Aptevo Therapeutics Inc.'s Compensation Committee.  As such, the equity award was split into two separate grants with the first portion of 11,000 options granted on March 4, 2022 and the second portion of 11,000 restricted stock units granted on June 7, 2022, following stockholder approval of an increase in shares available for issuance under the Aptevo Therapeutics Inc. 2018 Stock Incentive Plan (as Amended and Restated)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU vests in three approximately equal annual installments beginning on March 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSU vests in three approximately equal annual installments beginning on March 3, 2023."}],"balance_after":11000,"derivative":{"underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-22-034876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000120919122034876/doc4.xml","form_type":"4"}},{"id":2245186,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC and Corporate Affairs"}}],"security":"Restricted Stock Unit","published_at":"2022-06-03T19:13:54.000Z","date":"2022-06-01","kind":"exercise","acquired":false,"shares":1833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 1, 2021, the reporting person was granted 5,500 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 1, 2021, the reporting person was granted 5,500 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":3667,"derivative":{"underlying":"Common Stock","underlying_shares":1833},"source":{"system":"sec-edgar","filing":"0001209191-22-033933","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000120919122033933/doc4.xml","form_type":"4"}},{"id":2245185,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC and Corporate Affairs"}}],"security":"Common Stock","published_at":"2022-06-03T19:13:54.000Z","date":"2022-06-01","kind":"exercise","acquired":true,"shares":1833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":1833,"source":{"system":"sec-edgar","filing":"0001209191-22-033933","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000120919122033933/doc4.xml","form_type":"4"}},{"id":2350699,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC, and Corporate Affairs"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-04T23:07:07.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three approximately equal annual installments beginning on March 3, 2023."}],"balance_after":11000,"derivative":{"exercise_price":5.3,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-22-016448","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000120919122016448/doc4.xml","form_type":"4"}},{"id":2687051,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Unit","published_at":"2021-06-02T23:31:16.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units (the \"RSUs\") convert into shares of the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":5500,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001019056-21-000351","document":"kwon.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000101905621000351/kwon.xml","form_type":"4"}},{"id":2687050,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25060,"kind":"person","name":"Kwon SoYoung","position":1,"cik":"0001864406","reported_name":"Kwon SoYoung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-06-02T23:31:16.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":16500,"derivative":{"exercise_price":26.15,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001019056-21-000351","document":"kwon.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864406/000101905621000351/kwon.xml","form_type":"4"}}]}